[1]
|
魏艳丽. 重症急性胰腺炎的治疗现状[J]. 医学信息, 2021, 34(19): 55-57.
|
[2]
|
Hines, O.J. and Pandol, S.J. (2019) Management of Severe Acute Pancreatitis. BMJ, 367, l6227.
https://doi.org/10.1136/bmj.l6227
|
[3]
|
韩雪, 陈治国, 郝欣. 低分子肝素治疗重症急性胰腺炎疗效的META分析[J]. 中华医院感染学杂志, 2021, 31(1): 99-104.
|
[4]
|
Hao, C., Sun, M., Wang, H., et al. (2019) Low Molecular Weight Heparins and Their Clinical Applications. Progress in Molecular Biology and Translational Science, 163, 21-39. https://doi.org/10.1016/bs.pmbts.2019.02.003
|
[5]
|
Tozlu, M., Kayar, Y., Ince, A.T., et al. (2019) Low Molecular Weight Heparin Treatment of Acute Moderate and Severe Pancreatitis: A Randomized, Controlled, Open-Label Study. The Turkish Journal of Gastroenterology: The Official Journal of Turkish Society of Gastroenterology, 30, 81-87.
|
[6]
|
Sarr, M.G. (2013) 2012 Revision of the Atlanta Classification of Acute Pancreatitis. Polskie Archiwum Medycyny Wewnetrznej, 123, 118-124. https://doi.org/10.20452/pamw.1627
|
[7]
|
杜奕奇, 陈其奎, 李宏宇, 等. 中国急性胰腺炎诊治指南(2019年, 沈阳) [J]. 临床肝胆病杂志, 2019, 35(12): 2706-2711.
|
[8]
|
郑智, 曲元旭, 丁乙轩, 等. 急性胰腺炎发病机制的研究进展[J]. 中华肝胆外科杂志, 2021, 27(2): 152-155.
|
[9]
|
Watanabe, T., Kudo, M. and Strober, W. (2017) Immunopathogenesis of Pancreatitis. Mucosal Immunology, 10, 283-298. https://doi.org/10.1038/mi.2016.101
|
[10]
|
Lu, X.S., et al. (2009) Low Molecular Weight Heparin in the Treatment of Severe Acute Pancreatitis: A Multiple Centre Prospective Clinical Study. Asian Journal of Surgery, 32, 89-94. https://doi.org/10.1016/S1015-9584(09)60017-8
|
[11]
|
陈茹茹, 罗厚江, 杨军. 低分子量肝素作用机制及临床应用研究进展[J]. 中国现代医生, 2021, 59(6): 182-186.
|
[12]
|
Li, S., Zhang, S., Li, R., et al. (2020) Prophylactic Low-Molecular-Weight Heparin Administration Protected against Severe Acute Pancreatitis Partially by VEGF/Flt-1 Signaling in a Rat Model. Human & Experimental Toxicology, 39, 1345-1354. https://doi.org/10.1177/0960327120919469
|
[13]
|
魏巍. 低分子肝素治疗重症急性胰腺炎的效果研究[J]. 中国现代药物应用, 2021, 15(4): 201-203.
|
[14]
|
Lu, X.-S., et al. (2010) Effect of Lower-Molecular Weight Heparin in the Prevention of Pancreatic Encephalopathy in the Patient with Severe Acute Pancreatitis. Journal of the Pancreas, 39, 516.
https://doi.org/10.1097/MPA.0b013e3181c3c954
|
[15]
|
郭致平, 窦杰, 吴雪松, 等. 抗凝药物治疗重症急性胰腺炎的临床效果观察[J]. 昆明医科大学学报, 2017, 38(3): 35-38.
|
[16]
|
Qiu, Q., Li, G.J., Tang, L., et al. (2019) The Efficacy of Low Molecular Weight Heparin in Severe Acute Pancreatitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Digestive Diseases, 20, 512-522.
https://doi.org/10.1111/1751-2980.12815
|
[17]
|
Ke, L., et al. (2014) Efficacy of Continuous Regional Arterial Infusion with Low-Molecular-Weight Heparin for Severe Acute Pancreatitis in a Porcine Model. Shock (Augusta, Ga.), 41, 443-448.
https://doi.org/10.1097/SHK.0000000000000129
|
[18]
|
艾敏, 刘丽, 卢光明, 等. 低分子肝素钙持续性区域动脉灌注治疗重症急性胰腺炎8例[J]. 介入放射学杂志, 2019, 28(6): 533-536.
|
[19]
|
Portelli, M. and Jones, C.D. (2017) Severe Acute Pancreatitis: Pathogenesis, Diagnosis and Surgical Management. Hepatobiliary & Pancreatic Diseases International: HBPD INT, 16, 155-159.
https://doi.org/10.1016/S1499-3872(16)60163-7
|
[20]
|
伏添, 栾正刚, 张谞丰. 重症急性胰腺炎并发胰性脑病早期危险因素分析[J]. 东南国防医药, 2021, 23(3): 257-261.
|
[21]
|
张永国, 郭晓钟. 胰性脑病的诊治现状[J]. 临床肝胆病杂志, 2017, 33(1): 46-48.
|
[22]
|
Qiu, F., Lu, X.S. and Huang, Y.K. (2012) Protective Effect of Low-Molecular-Weight Heparin on Pancreatic Encephalopathy in Severe Acute Pancreatic Rats. Inflammation Research: Official Journal of the European Histamine Research Society, 61, 1203-1209. https://doi.org/10.1007/s00011-012-0517-8
|
[23]
|
程利. 高脂血症性胰腺炎的临床特点分析[J]. 当代医学, 2018, 24(34): 16-18.
|
[24]
|
王志毅, 许春芳, 陆婷, 等. 高脂血症性胰腺炎的临床分析[J]. 世界最新医学信息文摘(连续型电子期刊), 2019, 19(16): 40.
|
[25]
|
顾春俭. 低分子肝素联合加贝酯治疗高脂血症性胰腺炎疗效观察[J]. 临床医药文献电子杂志, 2017, 4(56): 10939-10940.
|
[26]
|
汤娜娜, 王晓燕, 赵成光, 等. 急性高脂血症性胰腺炎患者血清chemerin、降钙素原变化及意义[J]. 中华临床医师杂志(电子版), 2019, 13(1): 31-35.
|
[27]
|
戴伟, 周瑞祥, 严骏, 等. 低分子量肝素钙联合胰岛素治疗高脂血症性重症胰腺炎的临床观察[J]. 华中科技大学学报(医学版), 2020, 49(4): 500-503.
|
[28]
|
Rabenstein, T., Fischer, B., Wiessner, V., et al. (2004) Low-Molecular-Weight Heparin Does Not Prevent Acute Post-ERCP Pancreatitis. Gastrointestinal Endoscopy, 59, 606-613. https://doi.org/10.1016/S0016-5107(04)00159-2
|
[29]
|
Li, S., Cao, G., Chen, X., et al. (2012) Low-Dose Heparin in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Systematic Review and Meta-Analysis. European Journal of Gastroenterology & Hepatology, 24, 477-481. https://doi.org/10.1097/MEG.0b013e328351097f
|